Global Medical REIT Inc
NYSE:GMRE

Watchlist Manager
Global Medical REIT Inc Logo
Global Medical REIT Inc
NYSE:GMRE
Watchlist
Price: 7.735 USD -1.59% Market Closed
Market Cap: 516.7m USD
Have any thoughts about
Global Medical REIT Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one GMRE stock under the Base Case scenario is 17.729 USD. Compared to the current market price of 7.735 USD, Global Medical REIT Inc is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GMRE Relative Value
Base Case
17.729 USD
Undervaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.8
P/S
P/S
Price to Sales
3.8
vs History
76
vs Industry
42
Median 3Y
4.5
Median 5Y
5.3
Industry
3.6
Forward
3.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
11
Median 3Y
42.4
Median 5Y
40.9
Industry
16.7
Forward
-763.8
More Details
7.6
P/OCF
P/OCF
Price to OCF
7.6
vs History
68
vs Industry
42
Median 3Y
9
Median 5Y
9.8
Industry
10.9
More Details
36.9
P/FCFE
P/FCFE
Price to FCFE
36.9
vs History
9
vs Industry
21
Median 3Y
-5.6
Median 5Y
-4.8
Industry
13.3
More Details
1
P/B
P/B
Price to Book Value
1
vs History
52
vs Industry
31
Median 3Y
1.1
Median 5Y
1.1
Industry
0.8
More Details
8.4
EV/S
EV/S
Enterprise Value to Sales
8.4
vs History
76
vs Industry
37
Median 3Y
9.1
Median 5Y
10.8
Industry
6.6
Forward
8.1
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
11.9
More Details
12.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.6
vs History
68
vs Industry
47
Median 3Y
13.4
Median 5Y
15.1
Industry
15.8
Forward
11.5
More Details
32.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.8
vs History
41
vs Industry
16
Median 3Y
34
Median 5Y
34.1
Industry
19
Forward
31.7
More Details
16.8
EV/OCF
EV/OCF
Enterprise Value to OCF
16.8
vs History
66
vs Industry
37
Median 3Y
17.9
Median 5Y
18.9
Industry
18.5
More Details
20.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.8
vs History
9
vs Industry
30
Median 3Y
-8.1
Median 5Y
-5.7
Industry
20.1
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
53
vs Industry
25
Median 3Y
1
Median 5Y
1
Industry
0.7
More Details

Multiples Across Competitors

GMRE Competitors Multiples
Global Medical REIT Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Global Medical REIT Inc
NYSE:GMRE
520.4m USD 3.8 -368.6 12.6 32.8
US
Welltower Inc
NYSE:WELL
77.7B USD 10.4 84.9 32.8 79.1
US
Ventas Inc
NYSE:VTR
24.8B USD 5.1 -372.2 17.7 52.1
US
Physicians Realty Trust
NYSE:DOC
14.1B USD 5.5 45.7 14.4 38.1
US
Healthpeak Properties Inc
F:HC5
13.4B EUR 5.5 45.4 14.4 38.1
US
Omega Healthcare Investors Inc
NYSE:OHI
10.2B USD 10.1 29.3 16.3 24.8
US
Healthcare Realty Trust Inc
NYSE:HR
6.4B USD 4.8 -22.8 14.6 211
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 7.1 58.8 18.6 47.7
US
CareTrust REIT Inc
NYSE:CTRE
4.7B USD 17.3 47.1 20.3 26.6
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4B USD 5.8 41.4 15.4 26.1
US
National Health Investors Inc
NYSE:NHI
3B USD 9.2 23.8 16.2 22.3
P/E Multiple
Earnings Growth P/E to Growth
US
Global Medical REIT Inc
NYSE:GMRE
Average P/E: 47
Negative Multiple: -368.6
-68%
N/A
US
Welltower Inc
NYSE:WELL
84.9
309%
0.3
US
Ventas Inc
NYSE:VTR
Negative Multiple: -372.2 N/A N/A
US
Physicians Realty Trust
NYSE:DOC
45.7
-37%
N/A
US
H
Healthpeak Properties Inc
F:HC5
45.4
-37%
N/A
US
Omega Healthcare Investors Inc
NYSE:OHI
29.3
85%
0.3
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -22.8 N/A N/A
US
H
Healthcare Trust Of America Inc
F:HT01
58.8
N/A N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
47.1
417%
0.1
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
41.4
1 210%
0
US
National Health Investors Inc
NYSE:NHI
23.8
11%
2.1

See Also

Summary
GMRE intrinsic value, competitors valuation, and company profile.
DCF Valuation
GMRE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GMRE stock valuation using valuation multiples.
Wall Street Estimates
GMRE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GMRE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.